tranexamic acid has been researched along with Amyloid Angiopathy, Cerebral in 1 studies
Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Cerebral amyloid angiopathy is a devastating cause of intracerebral hemorrhage for which there is no specific secondary stroke prevention treatment." | 2.72 | Cerebral Amyloid Angiopathy and the Fibrinolytic System: Is Plasmin a Therapeutic Target? ( Cloud, GC; Keragala, CB; Markus, HS; Medcalf, RL; Mutimer, CA; Werring, DJ, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mutimer, CA | 1 |
| Keragala, CB | 1 |
| Markus, HS | 1 |
| Werring, DJ | 1 |
| Cloud, GC | 1 |
| Medcalf, RL | 1 |
1 review available for tranexamic acid and Amyloid Angiopathy, Cerebral
| Article | Year |
|---|---|
Cerebral Amyloid Angiopathy and the Fibrinolytic System: Is Plasmin a Therapeutic Target?
Topics: Amyloid beta-Peptides; Antibodies, Monoclonal; Antifibrinolytic Agents; Cerebral Amyloid Angiopathy; | 2021 |